Bagci, R. Et Al. 2019. Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice. TISSUE & CELL , vol.59 , 62-69.

Bagci, R., ŞAHİNTÜRK, V., & ŞAHİN, E., (2019). Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice. TISSUE & CELL , vol.59, 62-69.

Bagci, Ridvan, VAROL ŞAHİNTÜRK, And ERHAN ŞAHİN. "Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice," TISSUE & CELL , vol.59, 62-69, 2019

Bagci, Ridvan Et Al. "Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice." TISSUE & CELL , vol.59, pp.62-69, 2019

Bagci, R. ŞAHİNTÜRK, V. And ŞAHİN, E. (2019) . "Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice." TISSUE & CELL , vol.59, pp.62-69.

@article{article, author={Ridvan Bagci Et Al. }, title={Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice}, journal={TISSUE & CELL}, year=2019, pages={62-69} }